Shares of several companies in the broader cannabis and consumer discretionary sector, including Canopy Growth Corp CGC, are trading lower amid overall weakness as traders continue to digest Wednesday's Fed rate hike announcement.
The Federal Reserve raised its target fed funds rate by 0.5% on Wednesday to a new range of between 0.75% and 1.0%, its first rate hike of at least half a percentage point in more than 20 years. The Fed also said it will begin reducing the size of its balance sheet starting on June 1… Read More
Canopy Growth cultivates and sells medicinal and recreational cannabis.
The stock closed Thursday down 9% at $6.07. According to data from Benzinga Pro, Canopy Growth has a 52-week high of $26.96 and a 52-week low of $5.05.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.